A detailed history of Parnassus Investments, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Parnassus Investments, LLC holds 310,867 shares of BIO stock, worth $86.2 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
310,867
Previous 310,732 0.04%
Holding current value
$86.2 Million
Previous $104 Million 1.77%
% of portfolio
0.24%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$313.15 - $374.28 $42,275 - $50,527
135 Added 0.04%
310,867 $102 Million
Q2 2024

Aug 06, 2024

BUY
$268.26 - $339.48 $19.6 Million - $24.8 Million
72,942 Added 30.67%
310,732 $84.9 Million
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $4.58 Million - $6.21 Million
16,999 Added 7.7%
237,790 $76.8 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $77.3 Million - $93.3 Million
220,791 New
220,791 $79.1 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.83B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Parnassus Investments, LLC Portfolio

Follow Parnassus Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parnassus Investments, LLC with notifications on news.